Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rizkit is a pediatric nutritional supplement developed by LYS PHARMA, specifically formulated to support growth and appetite in children. The primary active ingredient is L-lysine, an essential amino acid that the body cannot synthesize on its own. L-lysine is vital for protein synthesis, collagen formation, and the absorption of calcium, all of which are critical for skeletal and muscular development in growing children. The supplement is typically used to address nutritional gaps, improve appetite, and promote healthy development. It is marketed primarily in South Korea as a growth-promoting aid for the pediatric population, often containing a combination of lysine and essential B-vitamins to support metabolic processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rizkit.